WO2013131994A3 - Coating for the diagnosis of inflammatory tissues in dental applications - Google Patents

Coating for the diagnosis of inflammatory tissues in dental applications Download PDF

Info

Publication number
WO2013131994A3
WO2013131994A3 PCT/EP2013/054571 EP2013054571W WO2013131994A3 WO 2013131994 A3 WO2013131994 A3 WO 2013131994A3 EP 2013054571 W EP2013054571 W EP 2013054571W WO 2013131994 A3 WO2013131994 A3 WO 2013131994A3
Authority
WO
WIPO (PCT)
Prior art keywords
coating
dental
base material
diagnosis
inflammatory tissues
Prior art date
Application number
PCT/EP2013/054571
Other languages
French (fr)
Other versions
WO2013131994A2 (en
Inventor
Falko Schlottig
Matthias Schnabelrauch
Lorenz Meinel
Ralf Wyrwa
Original Assignee
Thommen Medical Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thommen Medical Ag filed Critical Thommen Medical Ag
Publication of WO2013131994A2 publication Critical patent/WO2013131994A2/en
Publication of WO2013131994A3 publication Critical patent/WO2013131994A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/45—For evaluating or diagnosing the musculoskeletal system or teeth
    • A61B5/4538—Evaluating a particular part of the muscoloskeletal system or a particular medical condition
    • A61B5/4542—Evaluating the mouth, e.g. the jaw
    • A61B5/4552—Evaluating soft tissue within the mouth, e.g. gums or tongue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
    • A61C8/0012—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy
    • A61C8/0013—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy with a surface layer, coating

Abstract

The document proposes a coating for a fixed dental device, in particular for a dental implant, for a dental abutment, for a dental abutment screw and/or for a dental crown (as well as a device provided with such a coating) for identifying the presence of inflammatory tissues in the mouth, in particular adjacent to said device, comprising a base material or particles (3) embedded and/or attached to said base material; an element (1, 5-7) attached to said base material and/or said particles for the generation of a change in the coating directly detectable by the user; wherein the element (1, 5-7) generates the change upon direct or indirect contact with a marker (4) which is released by inflammatory tissue in response to bacterial mediators.
PCT/EP2013/054571 2012-03-08 2013-03-07 Coating for the diagnosis of inflammatory tissues in dental applications WO2013131994A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH3302012 2012-03-08
CH00330/12 2012-03-08

Publications (2)

Publication Number Publication Date
WO2013131994A2 WO2013131994A2 (en) 2013-09-12
WO2013131994A3 true WO2013131994A3 (en) 2013-10-31

Family

ID=47827236

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2013/054571 WO2013131994A2 (en) 2012-03-08 2013-03-07 Coating for the diagnosis of inflammatory tissues in dental applications

Country Status (1)

Country Link
WO (1) WO2013131994A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016189556A1 (en) * 2015-05-27 2016-12-01 Edierre Implant System S.P.A. Antimicrobial coating composition for dental implants
CN114805479B (en) * 2022-04-13 2024-02-13 锡林郭勒职业学院 Bioactive peptide with dipeptidyl peptidase IV inhibition activity

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999008730A1 (en) * 1997-08-15 1999-02-25 Children's Medical Center Corporation Osteopontin coated surfaces and methods of use
WO2002045661A1 (en) * 2000-12-08 2002-06-13 3M Espe Ag Use of moulding compounds for producing treatment devices
WO2002085250A2 (en) * 2001-04-19 2002-10-31 Mathys Orthopädie GmbH Biologically-functionalised, metabolically-inductive implant surfaces
WO2003020198A1 (en) * 2001-09-03 2003-03-13 Merck Patent Gmbh Use of collagen in the coating of tooth implants
WO2003059407A1 (en) * 2002-01-21 2003-07-24 Straumann Holding Ag Surface-modified implants
US20060275216A1 (en) * 1996-04-01 2006-12-07 Epix Pharmaceuticals, Inc., A Delaware Corporation Bioactivated diagnostic imaging contrast agents
WO2007133721A2 (en) * 2006-05-12 2007-11-22 Interleukin Genetics, Inc. Food compositions and methods of treating periodontal disease

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060275216A1 (en) * 1996-04-01 2006-12-07 Epix Pharmaceuticals, Inc., A Delaware Corporation Bioactivated diagnostic imaging contrast agents
WO1999008730A1 (en) * 1997-08-15 1999-02-25 Children's Medical Center Corporation Osteopontin coated surfaces and methods of use
WO2002045661A1 (en) * 2000-12-08 2002-06-13 3M Espe Ag Use of moulding compounds for producing treatment devices
WO2002085250A2 (en) * 2001-04-19 2002-10-31 Mathys Orthopädie GmbH Biologically-functionalised, metabolically-inductive implant surfaces
WO2003020198A1 (en) * 2001-09-03 2003-03-13 Merck Patent Gmbh Use of collagen in the coating of tooth implants
WO2003059407A1 (en) * 2002-01-21 2003-07-24 Straumann Holding Ag Surface-modified implants
WO2007133721A2 (en) * 2006-05-12 2007-11-22 Interleukin Genetics, Inc. Food compositions and methods of treating periodontal disease

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ALFANT BARNETT ET AL: "Matrix metalloproteinase levels in children with aggressive periodontitis", JOURNAL OF PERIODONTOLOGY, vol. 79, no. 5, 1 May 2008 (2008-05-01), pages 819 - 826, XP008152683, DOI: DOI:10.1902/JOP.2008.070513 *
GURSOY ULVI KAHRAMAN ET AL: "Use of host- and bacteria-derived salivary markers in detection of periodontitis: a cumulative approach", DISEASE MARKERS, vol. 30, no. 6, 2011, pages 299 - 305, XP008152652, ISSN: 1875-8630, DOI: DOI:10.3233/DMA-2011-0788 *
HERNÁNDEZ RÍOS MARCELA ET AL: "Proteolytic roles of matrix metalloproteinase (MMP)-13 during progression of chronic periodontitis: initial evidence for MMP-13/MMP-9 activation cascade", JOURNAL OF CLINICAL PERIODONTOLOGY, vol. 36, no. 12, 1 December 2009 (2009-12-01), pages 1011 - 1017, XP009147156, ISSN: 0303-6979 *
KIVELÄ-RAJAMÄKI M J ET AL: "Laminin-5-gamma-2-chain and collagenase-2 (MMP-8) in human peri-implant sulcular fluid", CLINICAL ORAL IMPLANTS RESEARCH, vol. 14, 1 January 2003 (2003-01-01), pages 158 - 165, XP002507773, ISSN: 0905-7161, DOI: 10.1034/J.1600-0501.2003.140204.X *
P. POZO ET AL: "Longitudinal analysis of metalloproteinases, tissue inhibitors of metalloproteinases and clinical parameters in gingival crevicular fluid from periodontitis-affected patients", JOURNAL OF PERIODONTAL RESEARCH, vol. 40, no. 3, 1 June 2005 (2005-06-01), pages 199 - 207, XP055029332, ISSN: 0022-3484, DOI: 10.1111/j.1600-0765.2005.00786.x *
TSCHESCHE H: "Bimolecular interaction of matrix metalloproteinases and their inhibitors timps", JOURNAL OF PROTEIN CHEMISTRY, vol. 17, no. 6, 1998, pages 549 - 551, XP019283958, ISSN: 0277-8033 *

Also Published As

Publication number Publication date
WO2013131994A2 (en) 2013-09-12

Similar Documents

Publication Publication Date Title
DOP2011000285A (en) 2-ACETAMIDO-5-ARIL-1, 2, 4-SUBSTITUTED TRIAZOLONS AND ITS USE
WO2013131993A3 (en) Chewing gum for the diagnosis of inflammatory tissues in dental applications
CL2012003026A1 (en) Pharmaceutical composition comprising pioglitazone and linagliptin; preparation procedure; Use in the treatment of type 2 diabetes or obesity.
WO2013142301A3 (en) Superabsorbent polymers and silicone elastomer for use in hair care compositions
UY31228A1 (en) ARILOXAZOLES REPLACED AND ITS USE
ECSP099581A (en) 4-ARIL-1,4-DIHIDRO-1,6-NAFTIRIDINAMIDES REPLACED AND ITS USE
WO2010119423A3 (en) Cosmetic compositions comprising oridonin and new cosmetic uses
BR112012010923A2 (en) bifidobacterium strain
BR112012031626A2 (en) pressure sensitive adhesive composition for skin application, layered adhesive construction, and medical device
BR112016000072A2 (en) oral compositions
PL2281022T3 (en) Thermally conductive adhesive mass
TNSN08381A1 (en) Cosmetic active ingredient composed of arginine ferrulate and a microalgae and extract its uses
WO2011059715A3 (en) Denture care composition
EP2488023A4 (en) Antimicrobial composition
ITMI20101824A1 (en) CONTROL AND PROCEDURE FOR THE CHOICE OF A CURVE RESISTANCE CHARACTERISTIC OF A THROTTLE PEDAL
UY31133A1 (en) "SUBSTITUTED OXAZOLIDINONES AND ITS USE"
FR2977256B1 (en) COMPOSITIONS OF 2,4,4,4-TETRAFLUOROBUT-1-ENE AND CIS-1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE
WO2013059233A3 (en) Thermoresponsive compositions for dermatological use and methods thereof
WO2013131994A3 (en) Coating for the diagnosis of inflammatory tissues in dental applications
IN2014DN03429A (en)
MY148570A (en) Health supplement composition of sea cucumber
WO2009132119A3 (en) Substituted oxazolidinones
WO2011128340A3 (en) Deodorant composition comprising violet nitrile
TW200733906A (en) Foot-use sheet and inner bottom of footwear using the same
FR2945213B1 (en) COSMETIC AND DERMATOLOGICAL AND DERMATOLOGICAL COMPOSITIONS BASED ON SILENE EXTRACT.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13707666

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 13707666

Country of ref document: EP

Kind code of ref document: A2